Showing results (971-980 of 1,798) with videos related to
Sort By:
Pageof 180
Npj Complexity|September 8, 2025
Assembly theory and its relationship with computational complexityChristopher P Kempes, Michael Lachmann, Andrew Iannaccone, et al.Anesthesia and Analgesia|March 12, 2019
Perioperatively Acquired WeaknessGunnar Lachmann, Rudolf Mörgeli, Sophia Kuenz, et al.Lancet (London, England)|June 16, 1990
Safety and efficacy of xenon in routine use as an inhalational anaestheticB Lachmann, S Armbruster, W Schairer, et al.Cancer Gene Therapy|July 24, 2002
Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicityRalf Kircheis, Elinborg Ostermann, Markus F Wolschek, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 15, 2017
Complement activation contributes to ventilator-induced lung injury in ratsB Petersen, T Busch, J Gaertner, et al.Pediatric Research|October 1, 1993
Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation techniqueH Segerer, W van Gelder, F W Angenent, et al.International Journal of Cancer|August 12, 2004
PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosomeMargit Lachmann, Dieter Gelbmann, Endre Kálmán, et al.Anaesthesia|April 1, 1990
Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxideF Boomsma, J Rupreht, A J Man in 't Veld, et al.Orphanet Journal of Rare Diseases|April 25, 2023
Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adultsRobin H Lachmann, George A Diaz, Melissa P Wasserstein, et al.Intensive Care Medicine|January 1, 1991
Effect of surfactant replacement on Pneumocystis carinii pneumonia in ratsE P Eijking, G J van Daal, R Tenbrinck, et al.Pageof 180